APOA1 and metabolic syndrome: In Brazil, 83.3% of the patients with JIA demonstrated dyslipidemia based on the TC, HDLc, LDLc, TG, non-HDLc, apolipoprotein A1 (ApoA1), and apolipoprotein B (ApoB) concentrations [68].